Michelle Kelliher to Immunotherapy
This is a "connection" page, showing publications Michelle Kelliher has written about Immunotherapy.
Connection Strength
0.175
-
Kelliher MA, Fitzgerald KA. TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy. Trends Immunol. 2023 03; 44(3):156-158.
Score: 0.175
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.